147 related articles for article (PubMed ID: 37908571)
1. Unilateral Graves' Disease in a Bilobar Thyroid Gland: A Very Unusual Cause of Hyperthyroidism.
Alaybaa K; Alhuzaim O
JCEM Case Rep; 2023 May; 1(3):luad048. PubMed ID: 37908571
[TBL] [Abstract][Full Text] [Related]
2. First reported case of unilateral Graves' disease in the left lobe of a bilobar thyroid gland.
Chen LC; Green JB
Thyroid; 2011 Jun; 21(6):683-6. PubMed ID: 21563918
[TBL] [Abstract][Full Text] [Related]
3. Graves' disease with only unilateral involvement; a case report.
Bu Bshait MS
Int J Surg Case Rep; 2024 Jan; 114():109138. PubMed ID: 38086135
[TBL] [Abstract][Full Text] [Related]
4. Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient.
Dimai HP; Ramschak-Schwarzer S; Lax S; Lipp RW; Leb G
J Endocrinol Invest; 1999 Mar; 22(3):215-9. PubMed ID: 10219891
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous occurrence of subacute thyroiditis and Graves' disease.
Hoang TD; Mai VQ; Clyde PW; Shakir MK
Thyroid; 2011 Dec; 21(12):1397-400. PubMed ID: 22136271
[TBL] [Abstract][Full Text] [Related]
7. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
8. A remarkable case of thyrotoxicosis initially caused by graves' disease followed by a probable TSHoma - a case report.
Quinn M; Bashari W; Smith D; Gurnell M; Agha A
BMC Endocr Disord; 2020 Aug; 20(1):133. PubMed ID: 32854689
[TBL] [Abstract][Full Text] [Related]
9. Two cases of Graves' disease with presentation of unilateral diffuse uptake of radioisotopes.
Sakata S; Fuwa Y; Goto S; Fukui M; Yuasa H; Takuno H; Sarui H; Matsui I; Ogawa T; Sasano N
J Endocrinol Invest; 1993 Dec; 16(11):903-7. PubMed ID: 8144868
[TBL] [Abstract][Full Text] [Related]
10. Graves' disease coexisted with resistance to thyroid hormone: a case report.
Akahori H; Usuda R
J Med Case Rep; 2021 Sep; 15(1):473. PubMed ID: 34560890
[TBL] [Abstract][Full Text] [Related]
11. Unilateral Graves' Disease: The Lesser Known.
Manthri RG; Ajit N; Vaikakkara S; Devi BV; Kalawat T
Indian J Nucl Med; 2019; 34(2):96-98. PubMed ID: 31040519
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine Therapy-Induced Conversion of Toxic Adenoma to Graves' Disease.
Rehman A; Obici S; Yaqub A
Cureus; 2020 Jun; 12(6):e8683. PubMed ID: 32699683
[TBL] [Abstract][Full Text] [Related]
13. A singular case of Graves' disease in congenital thyroid hemiagenesis.
Baldini M; Orsatti A; Cantalamessa L
Horm Res; 2005; 63(3):107-10. PubMed ID: 15775712
[TBL] [Abstract][Full Text] [Related]
14. Unilateral gynecomastia as an initial presentation of hyperthyroid Graves' disease.
Sakulterdkiat T; Romphothong K; Chatchomchuan W; Nakasatien S; Krittiyawong S; Thewjitcharoen Y; Himathongkam T
Endocrinol Diabetes Metab Case Rep; 2021 Nov; 2021():. PubMed ID: 34747364
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyrotropin receptor stimulating antibodies.
Teale E; Gouldesbrough DR; Peacey SR
Thyroid; 2006 Aug; 16(8):791-3. PubMed ID: 16910883
[TBL] [Abstract][Full Text] [Related]
16. Poorly Differentiated Thyroid Carcinoma Coexisting with Graves' Disease Involving T3 Thyrotoxicosis due to Increased D1 and D2 Activities.
Okazaki-Hada M; Maruoka A; Yamamoto M; Ito M; Hirokawa M; Nishikawa M; Akamizu T; Miyauchi A; Toyoda N
Thyroid; 2021 Oct; 31(10):1592-1596. PubMed ID: 34278816
[No Abstract] [Full Text] [Related]
17. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.
Kahaly GJ; Bartalena L; Hegedüs L; Leenhardt L; Poppe K; Pearce SH
Eur Thyroid J; 2018 Aug; 7(4):167-186. PubMed ID: 30283735
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
[TBL] [Abstract][Full Text] [Related]
19. Standardized grey scale ultrasonography in Graves' disease: correlation to autoimmune activity.
Schiemann U; Gellner R; Riemann B; Schierbaum G; Menzel J; Domschke W; Hengst K
Eur J Endocrinol; 1999 Oct; 141(4):332-6. PubMed ID: 10526244
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism.
Abbara A; Clarke SA; Brewster R; Simonnard A; Eng PC; Phylactou M; Papadopoulou D; Izzi-Engbeaya C; Sam AH; Wernig F; Jonauskyte E; Comninos AN; Meeran K; Kelsey TW; Dhillo WS
Front Endocrinol (Lausanne); 2020; 11():286. PubMed ID: 32477269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
